Rinaldetti, S., Worst, T., Weis, C. T., & Erben, P. (2017). FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes. OncoTarget, 8(29), . https://doi.org/10.18632/oncotarget.17394
Chicago-Zitierstil (17. Ausg.)Rinaldetti, Sébastien, Thomas Worst, Cleo-Aron Thias Weis, und Philipp Erben. "FOXM1 Predicts Overall and Disease Specific Survival in Muscle-invasive Urothelial Carcinoma and Presents a Differential Expression Between Bladder Cancer Subtypes." OncoTarget 8, no. 29 (2017). https://doi.org/10.18632/oncotarget.17394.
MLA-Zitierstil (9. Ausg.)Rinaldetti, Sébastien, et al. "FOXM1 Predicts Overall and Disease Specific Survival in Muscle-invasive Urothelial Carcinoma and Presents a Differential Expression Between Bladder Cancer Subtypes." OncoTarget, vol. 8, no. 29, 2017, https://doi.org/10.18632/oncotarget.17394.